Kala Bio, Inc. (LS:A4243T) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Kolchinsky Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Wave Life Sciences Ltd. (Director · Since at least Aug 14, 2015); Black Diamond Therapeutics, Inc. (Director · Jul 5, 2023 – Jul 5, 2023 · Past); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Research Alliance Corp II (Chief Executive Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Solid Biosciences Inc. (Director · Dec 10, 2020 – Jan 11, 2024 · Past); POINT Biopharma Global Inc (Chief Executive Officer, Director · Jul 7, 2020 – Jun 29, 2021 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Jun 8, 2022 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 3, 2022 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jun 19, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Jun 20, 2017 – Apr 2, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 27, 2019 · Past) | Director · Oct 3, 2018 – Mar 13, 2020 · Past |
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jul 19, 2017 – Jun 17, 2021 · Past |
| David Lazar Other companies: Aterian, Inc. (Chair of the Board · Since at least Apr 27, 2026); Quantum Cyber N.V. (CEO · Since at least Feb 13, 2026); Sow Good Inc. (Chief Executive Officer and Chair of the Board · Since at least Dec 31, 2025); Indaptus Therapeutics, Inc. (Director · Since at least Dec 22, 2025); Stablecoin Development Corporation (Chief Executive Officer, Director · Since at least Aug 19, 2025); Bio Green Med Solution, Inc. (Interim CEO · Jan 2, 2025 – Feb 26, 2025 · Past); LQR House Inc. (President, Director · Oct 15, 2024 – Apr 2, 2025 · Past); CapForce Inc. (Chief Executive Officer, Director · Mar 25, 2024 – Jul 30, 2024 · Past); FiEE, Inc (Director · Dec 29, 2023 – Feb 18, 2025 · Past); Titan Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 24, 2023 – Jul 26, 2023 · Past) | Chief Executive Officer, Director · Since at least Nov 23, 2025 |
| Andrew Koven Other companies: MetaVia Inc. (Chairman of the Board · Since at least Jul 9, 2021); Aralez Pharmaceuticals Inc (President & Chief Business Off · Feb 5, 2016 – Jun 4, 2018 · Past); POZEN Inc (President, Chief Business Ofc. · May 31, 2015 – Jun 3, 2015 · Past); Auxilium Pharmaceuticals Inc (EVP, CAO, GC and Secretary · Feb 3, 2012 – Jan 29, 2015 · Past); Inspire Pharmaceuticals Inc (EVP & Chief Admin & Legal Ofc · May 10, 2010 – May 13, 2011 · Past); Sepracor Inc (Exec VP, General Counsel · Mar 1, 2007 – Oct 20, 2009 · Past); Kos Pharmaceuticals Inc (EVP, General Counsel · Jan 26, 2006 – Dec 13, 2006 · Past) | Director · Since at least Sep 28, 2017 |
| Mark Iwicki Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Jade Biosciences, Inc. (Director · Apr 2, 2021 – Jun 5, 2024 · Past); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past); Aimmune Therapeutics Inc (Director · May 25, 2016 – Oct 10, 2020 · Past) | Director · Since at least Jul 19, 2017 |
| Robert Langer Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past); Ocata Therapeutics Inc (Director · Oct 4, 2011 – Feb 10, 2016 · Past) | Director · Jul 19, 2017 – Jun 12, 2018 · Past |
| Gregory D Perry Other companies: Novelion Therapeutics Inc (See Remarks · Nov 29, 2016 – May 9, 2017 · Past); Aegerion Pharmaceuticals Inc (See Remarks · Jul 6, 2015 – May 9, 2016 · Past); Eleven Biotherapeutics Inc (Chief Financial and Business · Feb 5, 2014 – Feb 26, 2015 · Past); InVivo Therapeutics Holdings Corp (Interim CFO · Sep 30, 2013 – Dec 30, 2013 · Past); Ocata Therapeutics Inc (Director · Dec 2, 2011 – Feb 10, 2016 · Past); ImmunoGen Inc (Chief Financial Officer · Jan 9, 2009 – Sep 10, 2013 · Past) | Director · Since at least Feb 28, 2018 |
| Robert I Tepper Other companies: Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jun 6, 2019 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 5, 2019 · Past); Jounce Therapeutics Inc (Director · Jan 26, 2017 – Jun 26, 2020 · Past); Dare Bioscience, Inc. (Director · Apr 10, 2014 – Jun 26, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Feb 3, 2015 · Past); Millennium Pharmaceuticals Inc (President, R&D · Sep 15, 2005 – Feb 12, 2007 · Past) | Director · Jul 19, 2017 – Jul 25, 2017 · Past |
| Mark Blumenkranz Other companies: Annexon, Inc. (BOARD MEMBER · Since at least Aug 10, 2026); IVERIC bio Inc (Director · Jul 15, 2020 – Jul 11, 2023 · Past); 1Life Healthcare Inc (Director · Jan 30, 2020 – Feb 22, 2023 · Past); Presbia PLC (Director · Jan 28, 2015 – Mar 16, 2015 · Past); Adverum Biotechnologies Inc (Director · Jul 30, 2014 – Feb 12, 2016 · Past) | Director · Nov 15, 2021 – Jun 11, 2024 · Past |
| Eric Trachtenberg Other companies: Aralez Pharmaceuticals Inc (GC, CCO & Secretary · Feb 5, 2016 – Mar 19, 2018 · Past); POZEN Inc (Deputy General Counsel · Jun 22, 2015 – Jun 22, 2015 · Past) | SEE REMARKS · Apr 2, 2018 – Jan 4, 2024 · Past |
| Howard B Rosen Other companies: Talphera, Inc. (Director · Feb 10, 2011 – Oct 10, 2023 · Past); Pharsight Corp (Director · Oct 31, 2008 – Oct 31, 2008 · Past) | Director · Since at least Jul 19, 2017 |
| Paulina Hill Other companies: Odyssey Therapeutics, Inc. (Director · Since at least May 7, 2026); Neuronetics, Inc. (Director · Jun 27, 2018 – Jul 2, 2018 · Past) | Director · Jul 19, 2017 – Jun 12, 2018 · Past |
| Todd Bazemore Other companies: Pulmatrix, Inc. (Chief Operating Officer · Since at least Oct 1, 2020); Dyax Corp (EVP & Chief Commercial Officer · Apr 16, 2014 – Jan 22, 2016 · Past) | Director · Since at least Nov 20, 2017 |
| C Daniel Myers Other companies: Alimera Sciences Inc (Director · Apr 21, 2010 – Jan 4, 2023 · Past) | Director · Since at least Oct 15, 2021 |
| Chaim D Berger Other companies: Nova Minerals Corp (Director · Since at least Mar 17, 2026) | Director · Since at least Jan 30, 2026 |
| Charles Douglas McDermott Other companies: Equillium, Inc. (Director · Since at least Oct 11, 2018) | President and Chief Bus. Off. · Jul 19, 2017 – Jul 19, 2017 · Past |
| Gregory Grunberg Other companies: 89bio Inc (Director · Nov 8, 2019 – Feb 9, 2023 · Past) | Director · Jul 19, 2017 – Jun 17, 2021 · Past |
| Romulus K Brazzell Other companies: Inspire Pharmaceuticals Inc (EVP, Medical & Scientific · Jan 19, 2006 – May 13, 2011 · Past) | SEE REMARKS · Since at least Jul 19, 2017 |
| Avi Minkowitz | Chief Executive Officer and Chief Financial Officer · Since at least Sep 29, 2026 |
| Avraham Minkowitz | Chief Executive Officer, Director · Since at least Jan 30, 2026 |
| Brendan P Purdy | Director · Since at least Jan 30, 2026 |
| Darius Kharabi | CHIEF BUSINESS OFFICER · Since at least Nov 15, 2021 |
| Hillel D Posen | Director · Since at least Jan 30, 2026 |
| Hongming Chen | CHIEF SCIENTIFIC OFFICER · Feb 7, 2018 – Oct 26, 2021 · Past |
| Marjan Farid | Director · Since at least Oct 31, 2022 |
| Mary Reumuth | CHIEF FINANCIAL OFFICER · Since at least Jul 19, 2017 |
| Michele LaRussa | Sr. VP, Regulatory and Quality · Jul 19, 2017 – Feb 7, 2018 · Past |
| Robert Bradley Paull | Director · Jul 19, 2017 – Jun 16, 2022 · Past |
| Yonatan C Colman | Director · Since at least Jan 30, 2026 |